| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68f2bd3d611c7a2a832128d8430d9193 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
| filingDate |
2008-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ec7f97aca86b406f7e21530c8071cad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_356adf67832afa9022a5572bfd067580
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_668052310e4b4bd1bbe7106f2ace70b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_861dd0c3205e7f5548217faa5a57d13e |
| publicationDate |
2010-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2938333-A1 |
| titleOfInvention |
MODULATORS OF CIDEA IN THE TREATMENT OF ACNE, SEBORRHEA DERMATITIS OR HYPERSEBORRHEA |
| abstract |
The invention relates to an in vitro or in vivo method for screening candidate compounds for the preventive or curative treatment of acne, seborrheic dermatitis or skin disorders associated with hyperseborrhoea comprising determining the capacity of a compound to modulate the expression or the activity of the protein CIDEA, as well as the use of modulators of the expression or the activity of this protein for the treatment of acne, seborrheic dermatitis or cutaneous disorders associated with a hyperseborrhea. The invention also relates to methods of diagnosis or prognosis in vitro of these pathologies. |
| priorityDate |
2008-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |